Naidus, Elliot
Bouquet, Jerome
Oh, David Y.
Looney, Timothy J.
Yang, Hai
Fong, Lawrence
Standifer, Nathan E.
Zhang, Li http://orcid.org/0000-0002-3617-2627
Funding for this research was provided by:
National Cancer Institute (4T32 CA177555, 1K08 AI139375, R01CA223484, U01CA233100.)
Conquer Cancer Foundation (Young Investigator Award)
Bladder Cancer Advocacy Network (Young Investigator Award)
Prostate Cancer Foundation (Young Investigator Award)
Article History
Received: 3 October 2020
Accepted: 15 December 2020
First Online: 9 January 2021
Compliance with ethical standards
:
: JB and NES are employees of AstraZeneca. DYO reports grants from Prostate Cancer Foundation (young investigator award) during the conduct of the study; other from Roche/Genentech (research support), Merck (research support), and personal fees from Maze Therapeutics (consulting) outside the submitted work. TJL was an employee of Thermo Fisher Scientific. LF reports grants and personal fees from Dendreon and grants and personal fees from BMS and Abbvie, Bavarian Nordic, Janssen, Merck, Roche/Genentech outside the submitted work. LZ reports personal fees from Dendreon (as a paid consultant), Smith-Kettlewell Eye Research Institute (as a paid consultant), and personal fees and other from Raydiant Oximetry Inc (as a paid consultant) outside the submitted work.
: The study was conducted in accordance with the principles of the Declaration of Helsinki, the International Conference on Harmonisation Good Clinical Practice guidelines, and local regulatory requirements. The study protocol was reviewed and approved by the Institutional Review Boards or Ethics Committees of the participating centers, and informed consent was obtained.